BP4101: Recombinant human C1qR mouse Fc fusion protein
Source: HEK 293 cell-derived.
Purity: >95% by SDS-PAGE under reducing conditions.
Activity: Recombinant human C1qR mouse Fc protein mediates the enhancement of phagocytosis.
Endotoxin Level: Less than 1 EU/ug of protein as determined by LAL method.BP4100: Recombinant human Fc gamma RIIIB protein
Source: HEK 293 cell-derived.
Purity: >95% by SDS-PAGE under reducing conditions.
Activity: Recombinant human Fc gamma RIIIB protein binds to human IgG as a low affinity receptor.
Endotoxin Level: Less than 1 EU/ug of protein as determined by LAL method.BP4099: Recombinant human Fc gamma RIIIA (V158) protein
Source: HEK 293 cell-derived.
Purity: >95% by SDS-PAGE under reducing conditions.
Activity: Recombinant human Fc gamma RIIIA (V158) protein binds to human IgG as a low affinity receptor.
Endotoxin Level: Less than 1 EU/ug of protein as determined by LAL method.BP4098: Recombinant human Fc gamma RIIIA (F158) protein
Source: HEK 293 cell-derived.
Purity: >95% by SDS-PAGE under reducing conditions.
Activity: Recombinant human Fc gamma RIIIA (F158) protein binds to human IgG as a low affinity receptor.
Endotoxin Level: Less than 1 EU/ug of protein as determined by LAL method.BP4097: Recombinant human Fc gamma RIIB/C protein
Source: HEK 293 cell-derived.
Purity: >95% by SDS-PAGE under reducing conditions.
Activity: Recombinant human Fc gamma RIIB/C protein binds to human IgG as a low affinity receptor.
Endotoxin Level: Less than 1 EU/ug of protein as determined by LAL method.BP4096: Recombinant human Fc gamma RIIA protein
Source: HEK 293 cell-derived.
Purity: >95% by SDS-PAGE under reducing conditions.
Activity: Recombinant human Fc gamma RIIA protein binds to human IgG as a low affinity receptor.
Endotoxin Level: Less than 1 EU/ug of protein as determined by LAL method.BP4094: Recombinant human Fc human Leptin fusion protein
Source: HEK 293 cell-derived.
Purity: >95% by SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU/ug of protein as determined by LAL method.BP000041-MPR10: Glucose-AGE-BSA
Modified with glucose for highest biological activity.
Activity: Measured by its binding to the immobilized RAGE in an ELISA binding assay.
Extent of AGE modification: 25-30 adducts per Glucose-AGE-BSA, as judged by free amine content analysis and MALDI-TOF analysis.
Can pair with biotinylated AGE-BSA (Cat# BP000042-MPR10) for competitive ELISA.
Endotoxin: < 0.1 EU/ug AGE-BSA as determined by the LAL method.BP000038-MPR11: Recombinant Human Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein
Source: E. Coli-derived.
Fully glycosylated and biologically active.BP000042-MPR10: Biotin-AGE-BSA
Efficiently biotinylated while preserving full activity.
Modified with glucose for highest biologic activity.
Can pair with AGE-BSA (Cat# BP000041-MPR10) for competitive ELISA.
Activity: KD 50-20 nM, as measured by its binding to the immobilized RAGE in an ELISA binding assay.
Extent of AGE modification: 25-30 adducts per Biotin-AGE-BSA, as judged by free amine content analysis and MALDI-TOF analysis.
Extent of biotinylation: 6-7 biotins per AGE-BSA, as judged by HABA assay and MALDI-TOF analysis.
Endotoxin: < 0.1 EU/ug AGE-BSA as determined by the LAL method.